Centanafadine

DB14841ApprovedInvestigationalSmall molecule

Centanafadine is a once-daily norepinephrine-dopamine-serotonin reuptake inhibitor and CNS stimulant indicated for ADHD in adults and pediatric patients. Centanafadine is a reuptake inhibitor at the norepinephrine, dopamine, and serotonin transporters and a central nervous system stimulant.

Chemical structure of Centanafadine
Mechanism
Curator reviewed · 2 references
Primary indication
Centanafadine is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients 6 years of age and older weighing at least 20 kg.Curator reviewed · 1 structured indication
Formula / weight
C15H15N · 209.292 g/mol (avg)
First approval
United States, 2026
Code names
EB-1020
Brand names
  • Simtriyo

Resolves to

Structure
InChIKeyHKHCSWPSUSWGLI-CABCVRRESA-NSMILESC1[C@@H]2CNC[C@]12C1=CC=C2C=CC=CC2=C1

What you can answer from here — as of November 03, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
364Drug interactionsStructured to mechanism, not free text
Sign in
17Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Centanafadine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account